ReVia and Vinorelbine Tartrate

• Generic Name: naltrexone
• Dosage Forms: tablet, film coated
• Other Brand Names: ReVia, Depade, Vivitrol

ReVia blocks the effects of opioid medication, including pain relief or feelings of well-being that can lead to opioid abuse. An opioid is sometimes called a narcotic. This medicine is used as part of a treatment program for drug or alcohol dependence.

ReVia is used to prevent relapse in people who became dependent on opioid medicine and then stopped using it. This medicine can help keep you from feeling a "need" to use the opioid.

ReVia is also used to treat alcoholism by reducing your urge to drink alcohol. This may help you drink less or stop drinking completely. This medicine will not cause you to "sober up" and will not decrease the effects of alcohol you recently consumed.

ReVia is not a cure for drug addiction or alcoholism.

ReVia may also be used for purposes not listed in this medication guide.

• Generic Name: vinorelbine
• Dosage Forms: n.a.
• Other Brand Names: Navelbine

Used alone or in combination with cisplatin as first-line therapy in ambulatory patients for the palliative treatment of unresectable, advanced non-small cell lung cancer (NSCLC).

Used alone or in combination with cisplatin in patients with Stage IV NSCLC.

Use in combination with cisplatin is preferred treatment of advanced NSCLC in patients with good performance status because of improved response and survival.

Used in combination with cisplatin in patients with Stage III NSCLC.

Use in combination with cisplatin is being investigated for adjuvant treatment of completely resected NSCLC.

Use in combination with trastuzumab is being investigated for the treatment of HER2-overexpressing metastatic breast cancer.

Has been used as first-line or salvage therapy for metastatic breast cancer in combination with various other agents, including anthracyclines (e.g., doxorubicin), fluoropyrimidines (e.g., fluorouracil, capecitabine), mitoxantrone, cisplatin, taxanes (e.g., docetaxel, paclitaxel), ifosfamide, or gemcitabine.

Has been used as monotherapy in first-line or salvage (e.g., second-line or subsequent) treatment of metastatic breast cancer.

Use in the treatment of metastatic or recurrent cervical cancer is being investigated.

Use in combination with other antineoplastic agents (e.g., cisplatin) is being evaluated in patients with metastatic or recurrent cervical cancer.

Has been used in the treatment of adult soft tissue sarcomas.

Has been used in the treatment of esophageal cancer.